GBC-001
B‑cell malignancies (CD19+)
Phase 1Active
Key Facts
About General Biologicals Corporation
Taiwan’s fast‑growing CDMO delivering end‑to‑end biologics manufacturing for oncology and immunology.
View full company profileB‑cell malignancies (CD19+)
Taiwan’s fast‑growing CDMO delivering end‑to‑end biologics manufacturing for oncology and immunology.
View full company profile